ArticleClinical & translational immunology2026
Unveiling the immune landscape and microenvironmental architecture of IgA nephropathy using single-cell imaging mass cytometry.
Article in Clinical & translational immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The heterogeneity in the pathology of IgA nephropathy (IgAN) represents a significant gap in current research, emphasising the need for individualised treatment strategies. The role of the glomerular microenvironment in driving IgAN heterogeneity remains largely unknown. Methods: This study employed Imaging Mass Cytometry (IMC) to analyse 34 primary IgAN renal biopsies. A panel of 35 protein markers was used to identify and characterise 17 cell clusters. Results: Immune cells composed of 9.64% of the glomerular cell population, with macrophages being the predominant subset. While there was no significant difference in the overall percentage of immune cells across glomeruli exhibiting different pathological features, including mesangial proliferation, global sclerosis, segmental sclerosis and crescents, the infiltration pattern of these cells was distinct. Neighbourhood analysis revealed that the interaction mode of M1-like macrophages varied significantly among these four glomerular pathology types. Severe IgAN (Lee grades IV-V) was associated with a lower glomerular M1/M2-like macrophage infiltration ratio compared to mild IgAN (Lee grade III). The M1/M2-like macrophage ratio positively correlated with the estimated glomerular filtration rate (eGFR), while M2-like macrophages correlated with proteinuria, and T cells were associated with haematuria. Conclusions: Our study findings underscore that glomerular immune cell subtypes and their interaction patterns critically influence pathological and clinical outcomes, suggesting a new potential direction for molecular therapeutic strategies targeting the IgAN microenvironment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.